Influence of torrefaction on the grindability and reactivity of woody biomass

7 pages, 5 figures, 4 tables.-- Available online Oct 23, 2007.The use of biomass to produce energy is becoming more and more frequent as it helps to achieve a sustainable environmental scenario. However the exploitation of this fuel source does have drawbacks that need to be solved. In this work, the torrefaction of woody biomass (eucalyptus) was studied in order to improve its properties for pulverised systems. The process consisted in a heating treatment at moderate temperature (240, 260, 280°C) under an inert atmosphere. The grindability of raw biomass and the treated samples was compared and an improvement in the grindability characteristics was observed after the torrefaction process. Thermogravimetric analysis of the samples was carried out in order to study their reactivity in air. The DTG curves of the torrefied biomass showed a double peak nature. The kinetic parameters were calculated for each reaction stage. The torrefaction process was found to influence the parameters of the first stage, whereas those corresponding to the second remained unaffected.This work was carried out with financial support from the Spanish CDTI (Project CENIT PiIBE) and ELCOGAS, S.A. M.G.P. and C.P. acknowledge the support from the CSIC I3P Program co-financed by the European Social Fund, and J.F. from the Plan Regional de Investigacion del Principado de Asturias.Peer reviewe

Future Research and Developments on Reuse and Recycling of Steelmaking By-Products

In the steel sector, sustainable management of by-products is a key challenge to preserve natural resources and achieve the zero waste goal. In this paper, the main trends of future research and development on reuse and recycling of by-products of the steel industry are presented in the form of a roadmap, which is the outcome of a dissemination project funded by the European Union based on the analysis of the most relevant and recent European projects concerning reuse and recycling of by-products from the steel production cycle. In particular, the developed roadmap highlights the most important topics of future research activities and challenges related to reuse and recycling of by-products from the existing or alternative steelmaking routes. A time horizon of 10 years has been considered, taking into account the European Commission targets to achieve carbon neutrality in a circular economy context. In addition, current technological trends derived from past and ongoing research projects are analysed. Research needs are based on the main categories of by-products and residual materials. Due to the different pathways to reduce CO2 emissions, each category is divided into subcategories considering both current and novel process routes targeting decarbonization of steel production. This work identifies the most urgent and demanding research directions for the coming years based on a survey targeting the steel companies, services providers of the steel industry and research organizations active in the field

CO2 mitigation for steelmaking using charcoal and plastics wastes as reducing agents and secondary raw materials

En: 1st Spanish National Conference on Advances in Materials Recycling and Eco – Energy Madrid, 12-13 November 2009.-- Editors: F. A. López, F. Puertas, F. J. Alguacil and A. Guerrero.-- 4 pages, 1 figure.The effects of the partial substitution of coal by charcoal or plastic wastes at two stages of the iron production, coking plant and blast furnace, were investigated in terms of the quality of the coke produced and the gasification behaviour in the raceway. From an environmental point of view, the routes proposed bring various potentials in terms of reducing CO2 emissions. The more efficient CO2 reductions ranging from 2 to 28 % imply the availability of biomass grown and charcoal production in a sustainable way, or C-neutral classification of plastic wastes.The authors thank the European Commission for financial support in the RFCS Programme (Contract number: RFSR-CT-2005-00001).Peer reviewe

Verwertung von getrocknetem Klaerschlamm und Huettenstaub durch Einblasen in den Kupolofen Schlussbericht

SIGLEAvailable from TIB Hannover: RA 3271(1.46.021) / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische InformationsbibliothekArbeitsgemeinschaft Industrieller Forschungsvereinigungen 'Otto von Guericke' e.V. (AIF), Koeln (Germany)DEGerman

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

BACKGROUND: Non-nephrotoxic immunosuppressive strategies that allow reduction of calcineurin-inhibitor exposure without compromising safety or efficacy remain a goal in kidney transplantation. Immunosuppression based on the mammalian-target-of-rapamycin inhibitor everolimus was assessed as a strategy for elimination of calcineurin-inhibitor exposure and optimisation of renal-graft function while maintaining efficacy. METHODS: In the ZEUS multicentre, open-label study, 503 patients (aged 18-65 years) who had received de-novo kidney transplants were enrolled. After initial treatment with ciclosporin, based on trough concentrations, and enteric-coated mycophenolate sodium (1440 mg/day, orally), corticosteroids (≥5 mg/day prednisolone or equivalent, orally), and basiliximab induction (20 mg, intravenously, on day 0 [2 h before transplantation], and on day 4), 300 (60%) patients were randomly assigned at 4·5 months in a 1:1 ratio to undergo calcineurin-inhibitor elimination (everolimus-based regimen that was based on trough concentrations [6-10 ng/mL] and enteric-coated mycophenolate sodium [1440 mg/day] with corticosteroids), or continue standard ciclosporin-based treatment. Randomisation was done by use of a central, validated system that automated the random assignment of treatment groups to randomisation numbers. The primary objective was to show better renal function (glomerular filtration rate [GFR]; Nankivell formula) with the calcineurin-inhibitor-free everolimus regimen at 12 months after transplantation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00154310. FINDINGS: 118 (76%) of 155 everolimus-treated patients and 117 (81%) of 145 ciclosporin-treated patients completed treatment with study drug up to 12 months after transplantation. At this timepoint, the everolimus regimen was associated with a significant improvement in GFR versus the ciclosporin regimen (71·8 mL/min per 1·73 m(2) vs 61·9 mL/min per 1·73 m(2), respectively; mean difference 9·8 mL/min per 1·73 m(2), 95% CI -12·2 to -7·5). Rates of biopsy-proven acute rejection were higher in the everolimus group than in the ciclosporin group after randomisation (15 [10%] of 154 vs five [3%] of 146; p = 0·036), but similar for the full study period (23 [15%] vs 22 [15%]). Compared with the ciclosporin regimen, higher mean lipid concentrations, slightly increased urinary protein excretion, and lower haemoglobin concentrations were noted with the everolimus regimen; thrombocytopenia, aphthous stomatitis, and diarrhoea also occurred more often in the everolimus group. A higher incidence of hyperuricaemia was noted with ciclosporin. INTERPRETATION: Early elimination of calcineurin inhibitor by use of everolimus-based immunosuppression improved renal function at 12 months while maintaining efficacy and safety, indicating that this strategy may facilitate improved long-term outcomes in selected patients. FUNDING: Novartis Pharma. Copyright © 2011 Elsevier Ltd. All rights reserved